Mizuho Securities Says UnitedHealth Group (UNH) Remains 'Largely Misunderstood' - PT to $156 Following 1Q
Mizuho Securities reiterated a Buy rating on UnitedHealth Group (NYSE: UNH), and raised the price target to $156.00 (from $150.00), following the company's 1Q earnings report. Guidance is up $0.15 to a range for adjusted EPS of $7.75 to $7.95.
Analyst Sheryl Skolnick commented, "UNH remains largely misunderstood and mispriced, a status that we think is directly related to a seeming unwillingness to listen to and believe what UNH says or what it has done. But with the extraordinary positive tone and strong balanced performance, more details around what Optum really does, we think that those who listen well will profit most. We up our ests and our PT from $150 to $156, and reiterate our Buy."
For an analyst ratings summary and ratings history on UnitedHealth Group click here. For more ratings news on UnitedHealth Group click here.
Shares of UnitedHealth Group closed at $130.50 yesterday.